Racial Disparities in Uterine Cancer Care

This research brief outlines significant racial disparities in the treatment and outcomes of uterine cancer, particularly focusing on Black patients compared to White patients. Key findings indicate that Black patients are less likely to receive guideline-concordant care, experience longer wait times for surgery and chemotherapy, and have a higher likelihood of their cancer becoming metastatic. Specifically, the analysis shows that only 24% of Black patients received surgery compared to 32% of White patients, and Black patients waited an average of three days longer for surgery. Furthermore, after chemotherapy, Black patients waited 12 days longer for symptom management medications. The brief discusses how systemic racism, barriers to access, and differences in insurance coverage contribute to these disparities. It emphasizes the need for increased public awareness and policy changes to address these inequities in healthcare and improve outcomes for Black patients with uterine cancer.